Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02548455 · ClinicalTrials.gov registry record · NA
Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study
A NA study of Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 499
- Enrollment target
- 20
- Study locations
NCT02548455 is a NA study of Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 499 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT02548455, a NA study of Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 499 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary intent of this study is to assess the safety of the model 1457Q Quartet LV lead at 3 months in a patient population indicated for cardiac resynchronization therapy.
Conditions Studied
Interventions
- DEVICE Quartet 1457Q LV Lead
Study Locations (20)
California
- Scripps Health - La Jolla
- Premier Cardiology, Inc. - Newport Beach
- Stanford University Hospital - Stanford
Florida
- Munroe Regional Medical Center - Ocala
- Tallahassee Research Institute - Tallahassee
Georgia
- Emory University Hospital - Atlanta
- North Georgia Heart Foundation - Gainesville
Kentucky
- Central Baptist Hospital - Lexington
- One Health Cardiology - Owensboro
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
Alabama
- Heart Center Research - Huntsville
Arizona
- Arizona Arrhythmia Research Center - Phoenix
Arkansas
- Cardiology Associates of Northeast Arkansas - Jonesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2015-10-27 |
| Est. Completion | 2017-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02548455
The ClinicalTrials.gov registry entry for NCT02548455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (76% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Quartet 1457Q LV Lead is the first listed.
NCT02548455 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT02548455 about?
NCT02548455 is a clinical study titled "Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study". The primary intent of this study is to assess the safety of the model 1457Q Quartet LV lead at 3 months in a patient population indicated for cardiac resynchronization therapy.
What is the current status of trial NCT02548455?
This trial is currently completed. It is a NA study. The enrollment target is 499 participants. The study started on 2015-10-27. Estimated completion is 2017-03-21.
What conditions does trial NCT02548455 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02548455?
The interventions under investigation include: Quartet 1457Q LV Lead (DEVICE).
Who is sponsoring clinical trial NCT02548455?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02548455 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.